Literature DB >> 23405332

Genome Sequence of the Attenuated Carbosap Vaccine Strain of Bacillus anthracis.

Robin Harrington1, Brian D Ondov, Diana Radune, Mary Beth Friss, Joy Klubnik, Lynn Diviak, Jonathan Hnath, Stephen R Cendrowski, Thomas E Blank, David Karaolis, Arthur M Friedlander, James P Burans, M J Rosovitz, Todd Treangen, Adam M Phillippy, Nicholas H Bergman.   

Abstract

The Bacillus anthracis Carbosap genome, which includes the pXO1 and pXO2 plasmids, has been shown to encode the major B. anthracis virulence factors, yet this strain's attenuation has not yet been explained. Here we report the draft genome sequence of this strain, and a comparison to fully virulent B. anthracis.

Entities:  

Year:  2013        PMID: 23405332      PMCID: PMC3569327          DOI: 10.1128/genomeA.00067-12

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Bacillus anthracis is a Gram-positive, spore-forming, filamentous bacillus and is the causative agent of anthrax in both animals and humans (1). B. anthracis strains attenuated for virulence in animals that were described in the latter part of the 19th century, and in particular, those put forward by Pasteur, soon came into use for vaccination against anthrax in cattle and sheep (2). Many attenuated strains of B. anthracis lack one of the two virulence-associated plasmids pXO1 and pXO2. The Sterne-type strains lack pXO2 and are toxigenic but cannot produce a capsule, while the Pasteur-type vaccine strains lack the pXO1 plasmid and are therefore encapsulated but nontoxigenic. Less commonly, other strains have been shown to be attenuated despite retaining both the pXO1 and pXO2 plasmids, which would normally result in full virulence (3, 4). One example of such a strain is B. anthracis Carbosap, used in Italy as a live spore vaccine for cattle and sheep (5). The Carbosap genome has been previously shown to contain sequences that indicate the presence of pXO1 and pXO2 as well as a limited set of chromosomal markers associated with virulence, and yet it shows significant attenuation of virulence in rabbits (5, 6, 7). In order to define the differences between Carbosap and other strains of B. anthracis that may explain its attenuation, we sequenced the genome of Carbosap. Genomic DNA was prepared from the Carbosap strain of B. anthracis (obtained from A. Fasanella) using standard methods (8) and sequenced using the 454 and Illumina MiSeq platforms. A total of 344,312 454 reads and 1,719,544 Illumina reads, totaling 390 Mb, were assembled using Newbler version 2.7 in both de novo and reference modes, using B. anthracis strain Ames Ancestor as a reference (9). Contigs from the de novo assembly that showed structural variation with respect to the reference were combined with the reference assembly using Minimus 2 (part of AMOS 3.1.0) to produce a draft genome of 5,402,970 bp and 21 contigs. Whole-genome single-nucleotide polymorphism (SNP) analysis showed that the Carbosap strain is a member of the trans-Eurasian clade of B. anthracis; the genome also contains 3 chromosomal deletions of 29, 24, and 3.5 kb relative to virulent strains of B. anthracis, consistent with previous array and PCR analyses (10). There were no major changes found in the Carbosap pXO1 and pXO2 sequences relative to plasmids from the Ames Ancestor strain. The chromosomal deletions contain >50 annotated genes, many of which have a known or proposed function that could be linked to virulence, so the precise nature of Carbosap’s attenuation remains unclear. A similar situation was recently reported for the B. anthracis CDC 684 strain (11), and it seems likely that in both cases further investigation into the functional effects of the genomic changes in these two strains will yield new insights into B. anthracis pathogenesis and aid in the identification of potential targets for development of new anthrax therapeutics.

Nucleotide sequence accession number.

This Whole Genome Shotgun project has been deposited at DDBJ/EMBL/GenBank under the accession no. ANAO00000000. The version described in this paper is the first version.
  10 in total

1.  Molecular study of genes involved in virulence regulatory pathways in Bacillus anthracis vaccine strain "Carbosap".

Authors:  Giuseppina La Rosa; Michele Muscillo; Michela Sali; Elena De Carolis; Cinzia Marianelli; Franco Ciuchini; Antonio Fasanella; Rosanna Adone
Journal:  New Microbiol       Date:  2006-10       Impact factor: 2.479

2.  The complete genome sequence of Bacillus anthracis Ames "Ancestor".

Authors:  Jacques Ravel; Lingxia Jiang; Scott T Stanley; Mark R Wilson; R Scott Decker; Timothy D Read; Patricia Worsham; Paul S Keim; Steven L Salzberg; Claire M Fraser-Liggett; David A Rasko
Journal:  J Bacteriol       Date:  2008-10-24       Impact factor: 3.490

3.  A simple "universal" DNA extraction procedure using SDS and proteinase K is compatible with direct PCR amplification.

Authors:  D Goldenberger; I Perschil; M Ritzler; M Altwegg
Journal:  PCR Methods Appl       Date:  1995-06

4.  Association of the encapsulation of Bacillus anthracis with a 60 megadalton plasmid.

Authors:  I Uchida; T Sekizaki; K Hashimoto; N Terakado
Journal:  J Gen Microbiol       Date:  1985-02

Review 5.  Anthrax infection.

Authors:  Daniel A Sweeney; Caitlin W Hicks; Xizhong Cui; Yan Li; Peter Q Eichacker
Journal:  Am J Respir Crit Care Med       Date:  2011-08-18       Impact factor: 21.405

6.  Detection of anthrax vaccine virulence factors by polymerase chain reaction.

Authors:  A Fasanella; S Losito; T Trotta; R Adone; S Massa; F Ciuchini; D Chiocco
Journal:  Vaccine       Date:  2001-07-20       Impact factor: 3.641

Review 7.  Anthrax vaccines: past, present and future.

Authors:  P C Turnbull
Journal:  Vaccine       Date:  1991-08       Impact factor: 3.641

8.  Evidence for plasmid-mediated toxin production in Bacillus anthracis.

Authors:  P Mikesell; B E Ivins; J D Ristroph; T M Dreier
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

9.  Sequence analysis of the genes encoding for the major virulence factors of Bacillus anthracis vaccine strain 'Carbosap'.

Authors:  R Adone; P Pasquali; G La Rosa; C Marianelli; M Muscillo; A Fasanella; M Francia; F Ciuchini
Journal:  J Appl Microbiol       Date:  2002       Impact factor: 3.772

10.  An attenuated strain of Bacillus anthracis (CDC 684) has a large chromosomal inversion and altered growth kinetics.

Authors:  Richard T Okinaka; Erin P Price; Spenser R Wolken; Jeffrey M Gruendike; Wai Kwan Chung; Talima Pearson; Gary Xie; Chris Munk; Karen K Hill; Jean Challacombe; Bruce E Ivins; James M Schupp; Stephen M Beckstrom-Sternberg; Arthur Friedlander; Paul Keim
Journal:  BMC Genomics       Date:  2011-09-30       Impact factor: 3.969

  10 in total
  1 in total

1.  Comparison of French and Worldwide Bacillus anthracis Strains Favors a Recent, Post-Columbian Origin of the Predominant North-American Clade.

Authors:  Gilles Vergnaud; Guillaume Girault; Simon Thierry; Christine Pourcel; Nora Madani; Yann Blouin
Journal:  PLoS One       Date:  2016-02-22       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.